AlloSource CEO to retire

AlloSource’s president and CEO, Tom Cycyota, plans to retire after leading the biologics company for 22 years.

Advertisement

Mr. Cycyota stepped into the role in 2000 and helped the company provide more than 3 million allografts for surgical procedures, according to an Aug. 2 news release. He will remain in his role until a successor is appointed.

AlloSource has more than 200 products for applications including spinal fusions, rotator cuff repairs and reconstruction surgery.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.